Pusic I, Miklos D, Cutler C, et al. Ibrutinib for chronic graft-versus-host disease after failure of frontline corticosteroids: results of a multicenter open-label phase 2-study. EHA 2017, S492.
Lager risico op abnormaal uterien bloedverlies met dabigatran ten opzichte van warfarine
jan 2017